SCHEMBL1923912

SCHEMBL1923912

Cc1ccc(NC(=O)Nc2ccc(-c3c(CCC(=O)O)c[nH]c3C(N)=O)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.48
PDGFRB P09619 4/20 0.48
KIF11 P52732 1/20 0.41
AKT2 P31751 1/20 0.40
MAPT P10636 2/20 0.40
CSF1R P07333 1/20 0.38
FLT1 P17948 1/20 0.38
FLT3 P36888 1/20 0.38
FFAR1 O14842 1/20 0.38
POLB P06746 2/20 0.38
STING1 Q86WV6 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PTPN7 P35236 1/20 0.38
ITGB1 P05556 1/20 0.38
ITGA4 P13612 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KIT P10721 1/20 0.38
TEK Q02763 1/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1924884 0.93 MEN1 (0.42) KDRPDGFRBAKT2MAPTCSF1R
SCHEMBL1924534 0.90 AURKA (0.44) KDRPDGFRBAKT2MAPTCSF1R
SCHEMBL1924620 0.90 CSF1R (0.53) KDRPDGFRBMAPTCSF1RFLT1
SCHEMBL1924876 0.89 AKT2 (0.42) KDRPDGFRBAKT2CSF1RFLT1
SCHEMBL1924464 0.89 ALDH1A1 (0.38) KDRPDGFRBAKT2MAPTFLT3
SCHEMBL1926602 0.88 KDM4E (0.46) KDRPDGFRBMAPTFLT3FFAR1
SCHEMBL1925746 0.88 ITGB1 (0.52) KDRPDGFRBMAPTFLT3MEN1
SCHEMBL1924610 0.87 MAPT (0.52) MAPTPOLBMEN1KMT2ASMN1; SMN2
SCHEMBL1925334 0.86 EPHX2 (0.48) KDRKIF11MAPTFFAR1STING1
SCHEMBL1924361 0.86 KMT2A (0.46) MAPTPOLBMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856043-B1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2011-06-08 EP claimed